Register for this 3 Day Pharma Mini MBA Training Course: May 3-5, 2023
20 févr. 2023 04h23 HE
|
Research and Markets
Dublin, Feb. 20, 2023 (GLOBE NEWSWIRE) -- The "The Pharma Mini MBA Training Course" conference has been added to ResearchAndMarkets.com's offering. Working in the highly competitive...
Register for This 3 Day Pharma Mini MBA Training Course: August 2 - 4, 2023 - Hear About the Latest Strategic Technology Innovations Being Used and Developed
17 févr. 2023 04h13 HE
|
Research and Markets
Dublin, Feb. 17, 2023 (GLOBE NEWSWIRE) -- The "The Pharma Mini MBA Training Course" conference has been added to ResearchAndMarkets.com's offering. Working in the highly competitive...
VPM oversees clinical trial and translational project management – Positive Phase I data of client Memo Therapeutics AG
25 janv. 2023 04h00 HE
|
VPM - Vakzine Project Management GmbH
HANNOVER, Germany, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Vakzine Projekt Management GmbH (VPM), a German drug development consultancy and service provider supporting small and medium pharma and biotech...
MMIT Announces the Winners of the Q3 2022 Patient Access Awards
06 janv. 2023 07h00 HE
|
Managed Markets Insight & Technology, LLC
Yardley, PA, Jan. 06, 2023 (GLOBE NEWSWIRE) -- Managed Markets Insight & Technology (MMIT)—the trusted go-to-market partner for overcoming barriers to patient access—has announced the winners of...
Syneos Health Adds HUB Patient Suite to Deployment Solutions Business
27 oct. 2022 07h30 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced it is introducing a dedicated...
Real Endpoints Marketplace announces collaboration with bluebird bio to help scale delivery of a first-of-its-kind value-based contract for one-time gene therapy
04 oct. 2022 00h01 HE
|
Real Endpoints
FLORHAM PARK, N.J., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Real Endpoints, the leading market-access platform and advisory firm, announced a collaboration with bluebird bio, inc. (Nasdaq: BLUE), to...
MMIT Announces the Winners of the Q2 2022 Patient Access Awards
26 sept. 2022 08h00 HE
|
Managed Markets Insight & Technology, LLC
Yardley, PA, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Managed Markets Insight & Technology (MMIT)—the trusted go-to-market partner for overcoming barriers to patient access—has announced the winners...
MMIT Announces the Winners of the Patient Access Awards
23 juin 2022 08h00 HE
|
Managed Markets Insight & Technology, LLC
Yardley, PA, June 23, 2022 (GLOBE NEWSWIRE) -- Managed Markets Insight & Technology (MMIT)—the trusted go-to-market partner for overcoming barriers to patient access—has launched the inaugural...
Amplity Health Appoints New National Account Leadership to Market Access Team
14 juin 2022 09h00 HE
|
Amplity Health
LANGHORNE, Pa., June 14, 2022 (GLOBE NEWSWIRE) -- Amplity Health, a leading global medical and commercial partner to biopharmaceutical companies, today announced a significant expansion to its...
MMIT Announces the Winners of the Seventh-Annual Specialty Pharmacy Patient Choice Awards
09 mai 2022 08h00 HE
|
Managed Markets Insight & Technology, LLC
Yardley, PA, May 09, 2022 (GLOBE NEWSWIRE) -- Managed Markets Insight & Technology (MMIT)—the trusted go-to-market partner for overcoming barriers to patient access—has announced the winners of...